Correlation Between Innovent Biologics and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Innovent Biologics and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovent Biologics and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovent Biologics and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Innovent Biologics and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovent Biologics with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovent Biologics and Cadrenal Therapeutics,.
Diversification Opportunities for Innovent Biologics and Cadrenal Therapeutics,
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Innovent and Cadrenal is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Innovent Biologics and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Innovent Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovent Biologics are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Innovent Biologics i.e., Innovent Biologics and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Innovent Biologics and Cadrenal Therapeutics,
Assuming the 90 days horizon Innovent Biologics is expected to generate 21.38 times less return on investment than Cadrenal Therapeutics,. But when comparing it to its historical volatility, Innovent Biologics is 13.92 times less risky than Cadrenal Therapeutics,. It trades about 0.03 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 0.15 in Cadrenal Therapeutics, Common on August 25, 2024 and sell it today you would earn a total of 1,499 from holding Cadrenal Therapeutics, Common or generate 999233.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 93.76% |
| Values | Daily Returns |
Innovent Biologics vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Innovent Biologics |
| Cadrenal Therapeutics, |
Innovent Biologics and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innovent Biologics and Cadrenal Therapeutics,
The main advantage of trading using opposite Innovent Biologics and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovent Biologics position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Innovent Biologics vs. Telix Pharmaceuticals Limited | Innovent Biologics vs. Keros Therapeutics | Innovent Biologics vs. MAIA Biotechnology | Innovent Biologics vs. Clarity Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance |